XML 18 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Changes In Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period Of Adoption, Adjustment
Common Stock
Preferred Stock
Additional Paid-in Capital
Retained Earnings
Retained Earnings
Cumulative Effect, Period Of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Beginning balance (in shares) at Dec. 31, 2018     106,375,000            
Beginning balance at Dec. 31, 2018 $ 2,054,998 $ 47,257 [1] $ 1,157 $ 0 $ 1,114,580 $ 1,192,767 $ 47,257 [1] $ (52,512) $ (200,994)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 93,072         93,072      
Other comprehensive income (loss) 49,702             49,702  
Common dividends declared (28,340)         (28,340)      
Repurchases of common stock (in shares)     (1,042,000)            
Repurchases of common stock (21,190)               (21,190)
Acquisitions, net of issuance costs (in shares)     4,879,000            
Acquisition, net of issuance costs 101,496   $ 47   97,351       4,098
Common stock issued (in shares)     30,000            
Common stock issued 605       (69)       674
Restricted stock activity (in shares)     353,000            
Restricted stock activity (3,770)       (13,320)       9,550
Treasury stock issued to benefit plans (in shares)     (6,000)            
Treasury stock issued to benefit plans (120)       (9)       (111)
Share-based compensation expense 6,863       6,863        
Ending balance (in shares) at Jun. 30, 2019     110,589,000            
Ending balance at Jun. 30, 2019 2,300,573   $ 1,204 0 1,205,396 1,304,756   (2,810) (207,973)
Beginning balance (in shares) at Mar. 31, 2019     106,900,000            
Beginning balance at Mar. 31, 2019 2,159,471   $ 1,157 0 1,103,991 1,273,245   (32,159) (186,763)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 47,014         47,014      
Other comprehensive income (loss) 29,349             29,349  
Common dividends declared (15,503)         (15,503)      
Repurchases of common stock (in shares)     (1,042,000)            
Repurchases of common stock (21,190)               (21,190)
Acquisitions, net of issuance costs (in shares)     4,729,000            
Acquisition, net of issuance costs 98,212   $ 47   98,165       0
Common stock issued (in shares)     3,000            
Common stock issued 68       68       0
Restricted stock activity (in shares)     1,000            
Restricted stock activity 5       (7)       12
Treasury stock issued to benefit plans (in shares)     (2,000)            
Treasury stock issued to benefit plans (37)       (5)       (32)
Share-based compensation expense 3,184       3,184        
Ending balance (in shares) at Jun. 30, 2019     110,589,000            
Ending balance at Jun. 30, 2019 $ 2,300,573   $ 1,204 0 1,205,396 1,304,756   (2,810) (207,973)
Beginning balance (in shares) at Dec. 31, 2019 109,972,000   109,972,000            
Beginning balance at Dec. 31, 2019 $ 2,370,793 $ (26,821) [2] $ 1,204 0 1,211,274 1,380,612 $ (26,821) [2] (1,954) (220,343)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 38,670         38,670      
Other comprehensive income (loss) 30,681             30,681  
Preferred dividends (1,037)         (1,037)      
Common dividends declared (32,017)         (32,017)      
Preferred stock issued 221,312     230,500 (9,188)        
Repurchases of common stock (in shares)     (1,171,000)            
Repurchases of common stock (22,557)               (22,557)
Acquisitions, net of issuance costs (in shares)     4,930,000            
Acquisition, net of issuance costs 71,883   $ 49   71,834        
Common stock issued (in shares)     43,000            
Common stock issued 930   $ 0   251       679
Restricted stock activity (in shares)     513,000            
Restricted stock activity (3,135)       (13,180)       10,045
Treasury stock issued to benefit plans (in shares)     (11,000)            
Treasury stock issued to benefit plans (168)       (21)       (147)
Share-based compensation expense $ 7,677       7,677        
Ending balance (in shares) at Jun. 30, 2020 114,276,000   114,276,000            
Ending balance at Jun. 30, 2020 $ 2,656,211   $ 1,253 230,500 1,268,647 1,359,407   28,727 (232,323)
Beginning balance (in shares) at Mar. 31, 2020     114,213,000            
Beginning balance at Mar. 31, 2020 2,435,707   $ 1,253 0 1,274,935 1,357,395   35,323 (233,199)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 19,064         19,064      
Other comprehensive income (loss) (6,596)             (6,596)  
Preferred dividends (1,037)         (1,037)      
Common dividends declared (16,015)         (16,015)      
Preferred stock issued 221,312     230,500 (9,188)        
Common stock issued (in shares)     6,000            
Common stock issued 79       79       0
Restricted stock activity (in shares)     64,000            
Restricted stock activity 31       (912)       943
Treasury stock issued to benefit plans (in shares)     (7,000)            
Treasury stock issued to benefit plans (89)       (22)       (67)
Share-based compensation expense $ 3,755       3,755        
Ending balance (in shares) at Jun. 30, 2020 114,276,000   114,276,000            
Ending balance at Jun. 30, 2020 $ 2,656,211   $ 1,253 $ 230,500 $ 1,268,647 $ 1,359,407   $ 28,727 $ (232,323)
[1] As a result of accounting guidance adopted in the first quarter of 2019, the remaining deferred gain on a sale-leaseback transaction was recognized as a cumulative-effect adjustment to retained earnings as of January 1, 2019.
[2] As a result of accounting guidance adopted in the first quarter of 2020, a portion of the increase in allowance for credit losses, net of tax, was recognized as a cumulative-effect adjustment to retained earnings as of January 1, 2020. For further discussion of this guidance, see Note 2, "Recent Accounting Pronouncements and Other Guidance."